Cartesian Therapeutics Inc

XNAS: RNAC

Weak Stock

Download real time

10.20 -0.24 (-2.30%)

75.64% Fall from 52W High

95,930 XNAS Volume

XNAS 13 May, 2025 5:30 PM (EDT)

264.2

Market Cap

Below industry Median

-0.1

Beta 1Year

Very Low volatility

Cartesian Therapeutics Inc - RNAC - stock price prediction, stock price target, analyst ratings from 8 analysts

Cartesian Therapeutics Inc has a share price target of US$ 36, revenue growth forecast of -91.4%, and profit growth estimate of -15.5% for FY25, based on top 8 analyst calls.

Forecaster Screeners